Cargando…
Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain
BACKGROUND: This study assessed pharmacoeconomic costs associated with extracorporeal photopheresis (ECP) compared with other available second‐line therapies for chronic graft‐vs‐host disease (cGvHD) in a tertiary Spanish institution. METHODS: Patients (≥18 years) diagnosed with steroid‐refractory c...
Autores principales: | Boluda, Blanca, Solana‐Altabella, Antonio, Cano, Isabel, Acuña‐Cruz, Evelyn, Rodríguez‐Veiga, Rebeca, Ballesta‐López, Octavio, Megías‐Vericat, Juan Eduardo, Martínez‐Cuadrón, David, Gómez, Ines, Solves, Pilar, Lorenzo, Ignacio, Piñana, Jose Luis, Sanz, Jaime, Guerreiro, Manuel, Montoro Gómez, Juan, Díaz‐González, Alvaro, Marco, Javier, Blanco, Albert, Sanz, Miguel Á., Montesinos, Pau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453768/ https://www.ncbi.nlm.nih.gov/pubmed/33964038 http://dx.doi.org/10.1002/jca.21901 |
Ejemplares similares
-
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
por: Megías-Vericat, Juan Eduardo, et al.
Publicado: (2022) -
Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
por: Solana-Altabella, Antonio, et al.
Publicado: (2022) -
IDH1-mutated relapsed or refractory AML: current challenges and future prospects
por: Megías-Vericat, Juan Eduardo, et al.
Publicado: (2019) -
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain
por: Boluda, Blanca, et al.
Publicado: (2018) -
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia
por: Boluda, Blanca, et al.
Publicado: (2023)